Professor Richard Scolyer, an Australian pathologist, applied his melanoma immunotherapy research to treat his own aggressive brain cancer, glioblastoma. His innovative approach led to a remission period of nearly two years, offering hope for future treatments. Although his cancer has returned, his case has paved the way for upcoming clinical trials. For more content like this, please visit: https://t.co/IMkI8zsszz #BrainCancer# #Immunotherapy# #MedicalInnovation# #Glioblastoma# #RichardScolyer#